A rating of 34 puts Abeona Therapeutics Inc (ABEO) near the middle of the Biotechnology industry according to InvestorsObserver. Abeona Therapeutics Inc's score of 34 means it scores higher than 34% of stocks in the industry. Abeona Therapeutics Inc also received an overall rating of 40, putting it above 40% of all stocks. Biotechnology is ranked 27 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Abeona Therapeutics Inc Stock Today?
Abeona Therapeutics Inc (ABEO) stock is unmoved -0.48% while the S&P 500 is lower by -1.28% as of 11:06 AM on Friday, Oct 2. ABEO is flat $0.00 from the previous closing price of $1.05 on volume of 1,099,195 shares. Over the past year the S&P 500 has gained 14.67% while ABEO is lower by -53.54%. ABEO lost -$1.31 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Abeona Therapeutics Inc (ABEO) Stock.
